Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer

Nursat Jahan; Francis Mogollon-Duffo; Shabnam Rehman; Sakshi Singal; Fred Hardwicke

doi:10.1200/JCO.2020.38.15_suppl.e17605

Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer

Nursat Jahan
, Francis Mogollon-Duffo
, Shabnam Rehman
, Sakshi Singal
, Fred Hardwicke

Department of Internal Medicine

Texas Tech University Health Sciences Center
Roswell Park Comprehensive Cancer Center

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	American English
Title of host publication	2020 ASCO Annual Meeting I
Subtitle of host publication	JOURNAL OF CLINICAL ONCOLOGY
Volume	38
Edition	15
DOIs	https://doi.org/10.1200/JCO.2020.38.15_suppl.e17605
State	Published - May 25 2020

Access to Document

10.1200/JCO.2020.38.15_suppl.e17605

Cite this

Jahan, N., Mogollon-Duffo, F., Rehman, S., Singal, S., & Hardwicke, F. (2020). Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer. In 2020 ASCO Annual Meeting I: JOURNAL OF CLINICAL ONCOLOGY (15 ed., Vol. 38). Article e17605 https://doi.org/10.1200/JCO.2020.38.15_suppl.e17605

Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer. / Jahan, Nursat; Mogollon-Duffo, Francis; Rehman, Shabnam et al.
2020 ASCO Annual Meeting I: JOURNAL OF CLINICAL ONCOLOGY. Vol. 38 15. ed. 2020. e17605.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Jahan, N, Mogollon-Duffo, F, Rehman, S, Singal, S & Hardwicke, F 2020, Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer. in 2020 ASCO Annual Meeting I: JOURNAL OF CLINICAL ONCOLOGY. 15 edn, vol. 38, e17605. https://doi.org/10.1200/JCO.2020.38.15_suppl.e17605

@inproceedings{76f27a8617424227b5088f276b3d4e3f,

title = "Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer",

author = "Nursat Jahan and Francis Mogollon-Duffo and Shabnam Rehman and Sakshi Singal and Fred Hardwicke",

year = "2020",

month = may,

day = "25",

doi = "10.1200/JCO.2020.38.15\_suppl.e17605",

language = "American English",

volume = "38",

booktitle = "2020 ASCO Annual Meeting I",

edition = "15",

}

TY - GEN

T1 - Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer

AU - Jahan, Nursat

AU - Mogollon-Duffo, Francis

AU - Rehman, Shabnam

AU - Singal, Sakshi

AU - Hardwicke, Fred

PY - 2020/5/25

Y1 - 2020/5/25

U2 - 10.1200/JCO.2020.38.15_suppl.e17605

DO - 10.1200/JCO.2020.38.15_suppl.e17605

M3 - Conference contribution

VL - 38

BT - 2020 ASCO Annual Meeting I

ER -